These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 8018944

  • 1. Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).
    Wang ZY, Chen Z, Huang W, Li XS, Lu JX, Huang LA, Zhang FQ, Gu LJ, Ouyang RR, Chen SJ.
    Blood Cells; 1993; 19(3):633-41; discussion 642-7. PubMed ID: 8018944
    [Abstract] [Full Text] [Related]

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 3. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Chim CS, Kwong YL, Liang R, Chu YC, Chan CH, Chan LC, Wong KF, Chan TK.
    Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
    [Abstract] [Full Text] [Related]

  • 4. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J, Shen ZX, Sun GL, Chen SJ, Wang ZY, Chen Z.
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [Abstract] [Full Text] [Related]

  • 5. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
    Marasca R, Zucchini P, Galimberti S, Leonardi G, Vaccari P, Donelli A, Luppi M, Petrini M, Torelli G.
    Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
    [Abstract] [Full Text] [Related]

  • 6. A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy.
    Naeem M, Harrison K, Barton K, Nand S, Alkan S.
    Eur J Haematol; 2006 Feb; 76(2):164-6. PubMed ID: 16405439
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA): a report of five-year experience].
    Sun GL.
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):125-9. PubMed ID: 8223122
    [Abstract] [Full Text] [Related]

  • 8. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP, Young JH, Lin TH, Yang YS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [Abstract] [Full Text] [Related]

  • 9. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
    Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA, PETHEMA Group.
    J Clin Oncol; 2005 Oct 20; 23(30):7632-40. PubMed ID: 16234524
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid and acute promyelocytic leukemia: a model of targetting treatment for human cancer.
    Chen Z, Chen SJ, Wang ZY.
    C R Acad Sci III; 1994 Dec 20; 317(12):1135-41. PubMed ID: 7697468
    [Abstract] [Full Text] [Related]

  • 11. Treatment of acute promyelocytic leukemia: a single institution experience.
    Ruiz-Argüelles GJ, Morales-Toquero A, Gómez-Rangel JD, López-Martínez B, Ruiz-Delgado GJ, Reyes-Núñez V.
    Rev Invest Clin; 2005 Dec 20; 57(3):415-9. PubMed ID: 16187701
    [Abstract] [Full Text] [Related]

  • 12. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM, Martín G, Gutiérrez NC, Cervera J, Ferro MT, Calasanz MJ, Martínez-Climent JA, Luño E, Tormo M, Rayón C, Díaz-Mediavilla J, González M, González-San Miguel JD, Pérez-Equiza K, Rivas C, Esteve J, Alvarez Mdel C, Odriozola J, Ribera JM, Sanz MA, PETHA Cooperative Group, Spain.
    Haematologica; 2001 Aug 20; 86(8):807-13. PubMed ID: 11522536
    [Abstract] [Full Text] [Related]

  • 13. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W, Wang H, Zhao W, Zhu J, Ju B, Wang X.
    Chin Med J (Engl); 2001 Jan 20; 114(1):30-4. PubMed ID: 11779431
    [Abstract] [Full Text] [Related]

  • 14. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    Varghese L, Janckila A, Yam LT.
    J Ky Med Assoc; 1999 Feb 20; 97(2):61-5. PubMed ID: 10073058
    [Abstract] [Full Text] [Related]

  • 15. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 20; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 16. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S.
    Haematologica; 1998 Nov 20; 83(11):985-8. PubMed ID: 9864917
    [Abstract] [Full Text] [Related]

  • 17. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
    Gupta V, Yi QL, Brandwein J, Lipton JH, Messner HA, Schuh AC, Wells RA, Minden MD.
    Leuk Res; 2005 Jan 20; 29(1):113-4. PubMed ID: 15541484
    [Abstract] [Full Text] [Related]

  • 18. Isoforms of PML-retinoic acid receptor alpha fused transcripts affect neither clinical features of acute promyelocytic leukemia nor prognosis after treatment with all-trans retinoic acid. The Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho).
    Fukutani H, Naoe T, Ohno R, Yoshida H, Miyawaki S, Shimazaki C, Miyake T, Nakayama Y, Kobayashi H, Goto S.
    Leukemia; 1995 Sep 20; 9(9):1478-82. PubMed ID: 7658715
    [Abstract] [Full Text] [Related]

  • 19. All-trans-retinoic acid treatment and retinoic acid receptor alpha gene rearrangement in acute promyelocytic leukemia: a model for differentiation therapy.
    Degos L.
    Int J Cell Cloning; 1992 Mar 20; 10(2):63-9. PubMed ID: 1312109
    [Abstract] [Full Text] [Related]

  • 20. Management of acute promyelocytic leukemia relapse in the ATRA era.
    Castagnola C, Lunghi M, Corso A, Tajana M, Zappasodi P, Dabusti M, Lazzarino M, Bernasconi C.
    Haematologica; 1998 Aug 20; 83(8):714-7. PubMed ID: 9793255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.